(Press-News.org) PHILADELPHIA — (TUESDAY, FEB. 3, 2026) — Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates. The innovative approach, published in Nature Immunology, could significantly shorten and simplify HIV vaccination protocols, making them more accessible worldwide.
The research, led by Amelia Escolano, Ph.D., assistant professor in Wistar’s Vaccine and Immunotherapy Center and the senior author of the study, centers on an engineered HIV envelope protein, WIN332, that challenges scientific assumptions about how to design an effective HIV vaccine.
“By going against one commonly held belief in the field, we achieved low neutralization after a single immunization, which was further increased after one additional booster, something that has never been observed before,” said Escolano. “Usually, HIV vaccination protocols require seven, eight, or even ten injections to start seeing any neutralization. For our immunogen, WIN332, we injected once and already saw some neutralization.”
For years, scientists attempting to engineer HIV vaccines have focused on targeting the virus’s envelope protein, a component of the outermost layer of the virus. Dr. Escolano’s team has engineered a specific region of the envelope protein, called the V3-glycan epitope. Conventional wisdom held that antibodies targeting this region required a particular sugar, N332-glycan, to bind effectively. All previous envelope immunogens were designed to preserve this sugar. Escolano’s team took the unprecedented step of removing the N332-glycan completely to create WIN332.
A single injection of WIN332 induced low but detectable neutralization against HIV within just three weeks—an unprecedented timeline. When the researchers gave a second injection using a related immunogen, neutralization levels increased significantly. This represents a potentially marked improvement over current experimental protocols.
“This immunogen could shorten and simplify vaccination protocols,” said Ignacio Relano-Rodriguez, Ph.D., first author of the study. “If this approach proves successful, we could potentially achieve desired immunity with just three injections. This would make vaccination protocols shorter and more affordable.”
By removing the N332-glycan to create their immunogen, the team also revealed the existence of two distinct types of HIV-neutralizing antibodies that target the V3-glycan region. Type I antibodies represent the previously known class that requires the N332 sugar to bind effectively. Type II antibodies are a new class, identified by this research, that doesn’t require the sugar for binding.
“This discovery potentially expands the toolkit available for developing HIV vaccines that provide broader protection against the diverse HIV strains circulating globally,” Escolano said.
The promising results have attracted attention from major global health organizations to advance WIN332 into human clinical trials. Meanwhile, additional preclinical evaluations are underway, along with the design of subsequent immunogens that could be used in a shortened vaccination series to further enhance neutralization efficiency.
Co-authors: Ignacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, Margaret Kerwin, Marta Tarquis-Medina, Eduardo Urbano, Jiayan Cui, Rumi Habib, Colby Agostino, Sukanya Ghosh, Joyce Park, Caroline Boroughs, Niharika Shukla, David B. Weiner, Daniel W. Kulp, and Jesper Pallesen from The Wistar Institute; Meagan Watkins and Ronald S. Veazey from Tulane National Primate Research Center; Peng Zhao and Lance Wells from University of Georgia; Michael S. Seaman from Beth Israel Deaconess Medical Center; Agnes A. Walsh, Mariane B. Melo, and Darrell J. Irvine from Scripps Research Institute; and George M. Shaw and Beatrice H. Hahn from University of Pennsylvania.
Work supported by: National Institute of Allergy and Infectious Diseases (NIAID) grants R00 AI140770-03, P30 AI045008-23, P30 AI045008-24, and R01 AI172627-01A1 to A.E.; Gates Foundation INV-036995 to A.E.; 5 U19 AI166916-03 to J.P. U19 AI166916, BEAT-HIV UM1AI64570, and the a W.W. Smith Charitable Trust Distinguished Professorship in Cancer Research to D.B.W. National Institutes of Health grants R01GM130915 and R01AI157854 to L.W.; National Science Foundation Biofoundry: Glycoscience Research, Education, and Training Grant 2400220 to L.W.; and The Ching Jer Chern Postdoctoral Fellowship to I.R.R.
Publication information: Rapid Elicitation of Neutralizing Asn332-glycan-independent Antibodies to the V3-glycan epitope of HIV-1 Env in Nonhuman Primates, Nature Immunology, 2026. Online publication.
###
The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the United States, Wistar has held the prestigious Cancer Center designation from the National Cancer Institute since 1972. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. wistar.org.
END
Wistar scientists demonstrate first-ever single-shot HIV vaccine neutralization success
2026-02-03
ELSE PRESS RELEASES FROM THIS DATE:
Medical AI models need more context to prepare for the clinic
2026-02-03
Medical artificial intelligence is a hugely appealing concept. In theory, models can analyze vast amounts of information, recognize subtle patterns in data, and are never too tired or busy to provide a response. However, although thousands of these models have been and continue to be developed in academia and industry, very few of them have successfully transitioned into real-world clinical settings.
Marinka Zitnik, associate professor of biomedical informatics in the Blavatnik Institute at Harvard Medical ...
Psilocybin shows context-dependent effects on social behavior and inflammation in female mice modeling anorexia
2026-02-03
CLAYTON, Victoria, AUSTRALIA, 3 February 2026 -- Researchers led by Dr. Claire Foldi at Monash University have discovered that psilocybin, the psychoactive compound found in magic mushrooms, produces subtle but distinct effects on social behavior and inflammation that depend critically on metabolic and exercise context in female mice. The peer-reviewed study, published in Psychedelics, represents the first systematic investigation of how this compound influences sociability in female mice exposed to activity-based anorexia (ABA), a widely ...
Mental health crisis: Global surveys expose who falls through the cracks and how to catch them
2026-02-03
NEWTON, Massachusetts, USA, 3 February 2026 -- In a comprehensive Genomic Press Interview published today in Genomic Psychiatry, Dr. Ronald C. Kessler, the McNeil Family Professor of Health Care Policy at Harvard Medical School, reflects on a career that fundamentally altered how researchers and policymakers across the globe understand the prevalence, distribution, and treatment of mental disorders. With secondary appointments as Professor of Epidemiology at the Harvard T.H. Chan School of Public Health, Program Director at the University of Michigan Institute for Social Research, and at the Massachusetts General Hospital Center for Precision Psychiatry, Dr. Kessler has built an unparalleled ...
New boron compounds pave the way for easier drug development
2026-02-03
A major step towards simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to increase the effect or reduce side effects without breaking down the medicine.
Chemical compounds based on the element boron are central tools in modern chemistry and are used, among other things, to build drugs, advanced materials, and molecules for medical diagnostics. Some types of boron compounds are still difficult to produce, especially when the boron atom must be placed very precisely in a complex molecule. This limits the possibilities for ...
Are cats ‘vegan’ meat eaters? Study finds why isotopic fingerprint of cat fur could trick us into thinking that way
2026-02-03
Cats – unlike humans – are true carnivores: they must eat meat to survive because their bodies can’t draw some essential nutrients from plants. By looking at tissues, researchers can get a good understanding of what foods animals ate.
Now, researchers at the Department of Microbiology and Ecosystem Science at the University of Vienna measured nitrogen and its stable isotopes 15N and 14N in the fur and whiskers of domestic cats as well as in cat food available in supermarkets. They then compared nitrogen isotope values to those found in the hair of humans ...
Unexpected partial recovery of natural vision observed after intracortical microstimulation in a blind patient
2026-02-03
A patient with complete blindness caused by irreversible optic nerve damage partially recovered natural vision after participating in a clinical trial of electrical stimulation of the visual cortex conducted by researchers from the Universidad Miguel Hernández de Elche (UMH) and the CIBER in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). The unexpected improvement was spontaneous, sustained over time, and independent of the implanted device.
The case was observed during a study designed to evaluate the safety and feasibility of a cortical visual prosthesis. Although the goal of the trial was to generate artificial visual ...
From sea to soil: Molecular changes suggest how algae evolved into plants
2026-02-03
Before plants evolved, vegetative life consisted of primitive green algae living in the sea. Like plants, these algae survived by performing photosynthesis, turning sunlight into energy. However, little light reaches the ocean where algae live; therefore, they evolved specialized organs to grab what little is available.
Among these tiny ocean algae are prasinophytes, which are among the earliest photosynthetic life forms on Earth. Like all photosynthetic organisms, they rely on a pigment–protein complex called LHC to capture sunlight. How efficiently LHC performs photosynthesis in different environments depends on the pigments ...
Landmark study to explore whether noise levels in nurseries affect babies’ language development
2026-02-03
Nearly two million children in the UK are affected by early language delays. New research will examine whether noise in nurseries is a hidden factor.
An estimated 1.9 million children across the UK are affected by early language delays, with rates doubling among children from disadvantaged backgrounds. A major new research project led by The Institute for the Science of Early Years (ISEY) at the University of East London supported by the Nuffield Foundation, will explore how background noise in nurseries affects early language development. The study ...
Everyday diabetes medicine could treat common cause of blindness
2026-02-03
Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries.
People with diabetes over the age of 55 years taking metformin were 37% less likely to develop the intermediate stage of AMD over a five year period compared to those not taking metformin.
AMD is a disease which affects the central retina or macular at the back of the eye. It eventually causes the light-sensitive tissue to die off (geographic atrophy, a form of ‘dry’ ...
Ultra-thin metasurface chip turns invisible infrared light into steerable visible beams
2026-02-03
New York, February 2, 2026 — The invention of tiny devices capable of precisely controlling the direction and behavior of light is essential to the development of advance technologies. Researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have taken a significant step forward with the developed of a metasurface that can turn invisible infrared light into visible light and aim it in different directions—without any moving parts. The details of their work are explained in a new paper published in the journal eLight.
The novel metasurface is constructed of an ultra-thin chip patterned with ...